Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPPS: Acebilustat and Camostat in COVID-19 Outpatients
NCT04662086Phase 2Completed
- Sponsor
- Stanford University
- Start
- Apr 2021
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acebilustat, camostat mesilate in coronavirus disease 2019 (COVID-19), sponsored by Stanford University. Started Apr 2021; status: completed.
02
Drugs
acebilustatcamostat mesilate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04662086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04662086.